Kymera Therapeutics · 7 hours ago
Protein Sciences and Lead Discovery Co-Op
Greater Boston
Full-time
Onsite
New Grad
$22/hr - $28/hrKymera Therapeutics is a clinical-stage biotechnology company focused on targeted protein degradation to develop innovative medicines. They are seeking a co-op student to assist with compound screening and biochemical/biophysical assay development, providing an opportunity to gain industry-relevant experience in early-stage projects.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Development and validation of fluorescence-based biochemical and biophysical assays to characterize protein-compound and/or protein-protein interactions
Assist in the discovery of chemical starting points for early-stage projects using screening technologies, including but not limited to DNA-encoded libraries, automated high-throughput fluorescence or activity-based assays, and fragment-based methods
Assist in the validation of screening hits using a suite of technologies including surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), thermal shift assays, dynamic light scattering, time-resolved FRET or fluorescence polarization-based assays, and NMR
Work with contract research organizations to oversee generation of protein reagents to facilitate biochemical/biophysical experiments
Qualification
Required
Currently pursuing a BS or MS degree in chemistry, biology, biochemistry, biophysics, biotechnology, or a related field
Hands-on laboratory experience in protein science, biochemistry, biophysics, or related fields
Ability to work well independently in a collaborative team environment
Comfortable in presenting results to small groups and cross-function teams
Ability to be onsite in Watertown, Ma July - December 2026 (start/end dates are flexible)
Preferred
Prior exposure to fluorescence-based techniques
Running assays in 384/1536-well format
Experience in protein sciences
Company
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Founded in 2017
51-200 employees
H1B Sponsorship
Kymera Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (2)
2023 (4)
2022 (3)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
Biotechnology Value FundAtlas Venture
2025-12-10Post Ipo Equity· $602M
2025-06-26Post Ipo Equity· $250.8M
2024-08-19Post Ipo Equity· $225M
Leadership Team
Nello Mainolfi
Founder, President and Chief Executive Officer
Jeremy Chadwick
Chief Operating Officer
Recent News
2026-01-16
2026-01-11
Company data provided by crunchbase